Literature DB >> 5314564

1-Methylisatin 3-thiosemicarbazone treatment of NZB x NZW hybrid mice.

R Gabriel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5314564      PMCID: PMC2072325     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


× No keyword cloud information.
  6 in total

1.  THE INFLUENCE OF ISATIN BETA-THIOSEMICARBAZONE ON THE DEVELOPMENT OF NEUROVACCINIA VIRUS IN CELLS AS SHOWN BY ELECTRON MICROSCOPY.

Authors:  D G O'SULLIVAN; P W SADLER; V RUSSELL
Journal:  Arch Gesamte Virusforsch       Date:  1964-06-17

2.  Pilot trial of an antiviral agent in malignant disease.

Authors:  T F Sandeman
Journal:  Br Med J       Date:  1966-09-10

3.  The inhibition of vaccinia virus multiplication by isatin-beta-thiosemicarbazone.

Authors:  B Woodson; W K Joklik
Journal:  Proc Natl Acad Sci U S A       Date:  1965-09       Impact factor: 11.205

4.  Methisazone in prevention of variola minor among contacts.

Authors:  L A do Valle; P R de Melo; L F de Gomes; L M Proença
Journal:  Lancet       Date:  1965-11-13       Impact factor: 79.321

5.  Particles resembling murine leukaemia virus in New Zealand black mice.

Authors:  P R Prosser
Journal:  Clin Exp Immunol       Date:  1968-03       Impact factor: 4.330

6.  Pathogenesis of the glomerulonephritis of NZB/W mice.

Authors:  P H Lambert; F J Dixon
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

  6 in total
  2 in total

1.  Therapeutic effect of beta-[1-phenyl-5-bis(beta-chloroethyl)-amino-benzimidazolyl-(2)-DL-alanin (ZIMET 3164) on immune complex nephritis of NZB hybrid mice.

Authors:  J Güttner
Journal:  Agents Actions       Date:  1979-12

2.  The effect of exogenous interferon: acceleration of autoimmune and renal diseases in (NZB/W) F1 mice.

Authors:  C Adam; Y Thoua; P Ronco; P Verroust; M Tovey; L Morel-Maroger
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.